VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 12:13:24 UTC 2023` Edited by `admin` on `Sat Dec 16 12:13:24 UTC 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	798536Z7S0
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2

Common Name

English

KDR

Common Name

English

FETAL LIVER KINASE 1

Common Name

English

PROTEIN-TYROSINE KINASE RECEPTOR FLK-1

Common Name

English

CD309

Common Name

English

VEGFR-2

Common Name

English

FLK-1

Common Name

English

KINASE INSERT DOMAIN RECEPTOR

Common Name

English

Code System Code Type Description

UNIPROT

P35968

Created by admin on Sat Dec 16 12:13:28 UTC 2023 , Edited by admin on Sat Dec 16 12:13:28 UTC 2023

PRIMARY

EC (ENZYME CLASS)

EC 2.7.10.1

Created by admin on Sat Dec 16 12:13:28 UTC 2023 , Edited by admin on Sat Dec 16 12:13:28 UTC 2023

PRIMARY

FDA UNII

798536Z7S0

Created by admin on Sat Dec 16 12:13:28 UTC 2023 , Edited by admin on Sat Dec 16 12:13:28 UTC 2023

PRIMARY

WIKIPEDIA

KINASE INSERT DOMAIN RECEPTOR

Created by admin on Sat Dec 16 12:13:28 UTC 2023 , Edited by admin on Sat Dec 16 12:13:28 UTC 2023

PRIMARY

From	To
1_34	1_84
1_131	1_181
1_227	1_288
1_426	1_511
1_552	1_623
1_669	1_718
1_1005	1_1026

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_27
N	1_47
N	1_77
N	1_124
N	1_139
N	1_226
N	1_299
N	1_355
N	1_376
N	1_492
N	1_504
N	1_561
N	1_594
N	1_600
N	1_612
N	1_656
N	1_685
N	1_702

Related Record Type Details


					5S371K6132

RIVOCERANIB

INHIBITOR -> TARGET

Interaction Type:

SELECTIVE

Qualification:

IC50

Amount:


					T678746713

ALTIRATINIB

INHIBITOR -> TARGET


					J8AY0Z4CBP

CEP-11981

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					Y7HJ4D4CRT

ODM-203

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					C9LVQ0YUXG

AXITINIB

INHIBITOR -> TARGET


					WZ9TJ0L9Y8

Tinengotinib

INHIBITOR -> TARGET

Amount:


					3K3KYC9LES

PF-337210

INHIBITOR -> TARGET

Amount:


					EE083865G2

LENVATINIB

INHIBITOR -> TARGET


					3750D0U8B5

PEXMETINIB

INHIBITOR -> TARGET

Amount:


					ZL9780F883

ALACIZUMAB PEGOL

INHIBITOR -> TARGET


					9ZOQ3TZI87

SORAFENIB

INHIBITOR -> TARGET


					VKU5X213Q7

BMS-690514

INHIBITOR -> TARGET


					24T2A1DOYB

REGORAFENIB ANHYDROUS

INHIBITOR -> TARGET


					W1B375O5M2

CP-547632

INHIBITOR -> TARGET


					FA3HNX7HP6

TIMTRAXANIB

INHIBITOR -> TARGET

Amount:


					6L5D03D975

ILORASERTIB

INHIBITOR -> TARGET

Amount:


					1WPE73O1WV

PRALSETINIB

INHIBITOR->OFF-TARGET

Qualification:

IC50

Amount:


					7Q29OXD98N

GLESATINIB

INHIBITOR -> TARGET


					ZZ6VH5MZ17

SU-14813

INHIBITOR -> TARGET


					4340891KFS

PONATINIB

INHIBITOR -> TARGET


					QTW8MQ534B

DMBI

INHIBITOR -> TARGET


					1C39JW444G

CABOZANTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					YP8G3I74EL

VOROLANIB

INHIBITOR -> TARGET


					SJ9PP5S9IM

AZD-2932

INHIBITOR -> TARGET

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					G1PEG5Q9Y2

OSI-930

INHIBITOR -> TARGET

Interaction Type:

COMPETITIVE INHIBITOR


					T1IV236CVP

BFH-772

INHIBITOR -> TARGET


					EJL21Y5LKT

VARISACUMAB

INHIBITOR -> TARGET


					B2K5L1L8S9

SURUFATINIB

INHIBITOR -> TARGET

Amount:


					FDL8DA4XV4

PULOCIMAB

LIGAND->TARGET

Amount:


					FHX0K077F6

6-(4-METHOXYPHENYL)-3-(3-THIENYL)-PYRAZOLO(1,5-A)PYRIMIDINE

INHIBITOR -> TARGET


					9NPC24K8FA

VEGFR 2 KINASE INHIBITOR II

INHIBITOR -> TARGET


					81FH7VK1C4

FORETINIB

INHIBITOR -> TARGET


					DDU33B674I

BRIVANIB

INHIBITOR -> TARGET


					GKF8S4C432

Catequentinib

INHIBITOR -> TARGET

Amount:


					E1V875I8DX

KRN-633

INHIBITOR -> TARGET


					1C7AZL970U

SU-11652

INHIBITOR -> TARGET


					NQU9IPY4K9

CEDIRANIB

INHIBITOR -> TARGET


					ID912S5VON

MIDOSTAURIN

INHIBITOR -> TARGET


					CEGM9YBNGD

Selpercatinib

INHIBITOR->OFF-TARGET

Qualification:

IC50

Amount:


					G6HRD2P839

NINTEDANIB

INHIBITOR -> TARGET


					18P7197Q7J

TELATINIB

INHIBITOR -> TARGET

Amount:


					768FW21J3L

FAMITINIB

INHIBITOR -> TARGET


					F2CB8801I3

ACRIZANIB

INHIBITOR -> TARGET


					9RL37ZZ665

ORANTINIB

INHIBITOR -> TARGET


					5B9VB06146

PP-121

INHIBITOR -> TARGET


					SSB56T0M0L

PEGDINETANIB

INHIBITOR -> TARGET


					980M4N37DH

JI-101

INHIBITOR -> TARGET


					U1JK633AYI

MOTESANIB

INHIBITOR -> TARGET


					78I4VEX88N

AGERAFENIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					CWG62Q1VTB

SITRAVATINIB

INHIBITOR -> TARGET

Amount:


					V99T50803M

SUNITINIB

INHIBITOR -> TARGET


					172030934T

TIVOZANIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					MC20MXE412

N-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N'-(4-FLUORO-2-(SULFOOXY)PHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					SA09JNQ24D

VULINACIMAB

INHIBITOR -> TARGET


					F6XM2TN5A1

TESEVATINIB

INHIBITOR -> TARGET


					7RN5DR86CK

PAZOPANIB

INHIBITOR -> TARGET


					J6U9WP10T7

ENMD-981693

INHIBITOR -> TARGET

Amount:


					YO460OQ37K

VANDETANIB

INHIBITOR -> TARGET

Amount:


					PP449XA4BH

LUCITANIB

INHIBITOR -> TARGET

Amount:


					49DXG3M5ZW

FRUQUINTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					PW3Q92Z6A4

NINGETINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					H2OL3Q4XRD

PAMUFETINIB

INHIBITOR -> TARGET

Comments:

ATP COMPETITIVE

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					U07H877HUF

VEGFR 2 KINASE INHIBITOR I

INHIBITOR -> TARGET


					WD3N2P38NO

3-HYDROXY-APATINIB, TRANS-

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					F40IRN5981

Ibcasertib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					KC2JC2ZA04

Zanzalintinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL